CD44 and cancer: Thus, the focus has become polymorphisms in well-known cancer associated genes, such as CD44. The meta-analysis performed here with data pooled from 5,788 cases and 5,852 controls supports previous findings that a significant association between CD44 polymorphism rs13347 and cancer risk exists under all genetic models.